Counterfeit drugs worth €10.5bn ($14.3bn) are sold in Europe each year with Germans and Italians being the biggest consumers of such products, according to new Pfizer sponsored research.
Clinical trials are often biased against the recruitment of older people says the European Union's PREDICT group, which has launched a charter designed to protect such patients' right to take part.
Rusnano, the group set up to promote Russia’s nanotechnology infrastructure, says nanodrug development partnership will improve patient access and cut cancer death rates across the country.
Capsugel says latest addition to its Xcelodose range, Xcelolab, provides a rapid and reproducible solution for dispensing small amounts of pharmaceutical powders during laboratory stage drug development.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Lonza, Quanticate, BioClinica, TechTeam and Norwich Pharmaceuticals.
The US Food and Drug Administration (FDA) has issued guidance on the use of Bayesian analysis in clinical trials of medical devices and says the technique can cut costs and boost efficiency.
Companies are failing to protect their products with tamper evidence but the EU falsified medicine directive, plus the ease of implementation, will drive adoption, according to a director at Schreiner ProSecure.
Parexel has formed an alliance with Proteome Sciences to enhance its biomarker capabilities, allowing it to help clients make earlier assessments of new compounds in development.
Cambrex reported a dip in revenues in 2009, citing the timing of orders throughout the year, and warned that smaller clients’ funding difficulties and pricing pressures will continue in 2010.
US CDMO Avrio Biopharmaceuticals’ new aseptic fill-and-finish facility in Irvine, California has been approved for the manufacture of biologics by state drug regulators.
Using intelligent compliance packaging in clinical trials can result in “huge cost savings” and this will ensure demand even during a period of cost-cutting, according to a sales manager at Stora Enso.
Gerresheimer expects pharmaceutical packaging sales to grow but says performance of “cyclical” cosmetics and life science businesses is more difficult to predict.
Consolidation in pharma, coupled to the trend for strategic partnerships, will lead to CRO mergers, with large companies getting bigger and small firms focusing on niche opportunities, according to a report.
MDS has agreed to sell its Pharma Services division, with a CRO and private investors lined up to buy different sites, but approximately 275 employees will lose their jobs during the transition.
The WHO has stopped sending free drugs to private hospitals and non-governmental organisations in Haiti after receiving reports that some institutions in the earthquake stricken country had begun to charge patients.
Almac Pharma Services has bolstered its product development offering with a new Xcelodose 600s precision powder micro-dosing system that, it claims, can cut processing time, API usage and costs.
CRO NexMed has received a $2.7m (€2.0m) cash boost, which improves its financial situation and provides funds to develop its NexACT technology for oral and transdermal delivery.
SIRO Clinpharm has formed an alliance with South Korea-based CRO DreamCIS to expand its clinical trial offering in Asia Pacific and provide clients with more options for patient recruitment.
US biotechnology firm NexBio has received a patent for “pioneering” host cell-targeting influenza drugs that can cut the risk of viral mutation and the emergence of drug resistant strains.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at GlaxoSmithKline, Synthon, BioSante and Xencor.
US contract research organisation (CRO) PPD reported a “higher than anticipated” number of cancellations in Q4, bringing to a close 12 months that saw operating income fall 46 per cent to $192m.
Falling preclinical demand may have dominated Charles River Laboratories’ (CRL) performance in 2009, but stagnant sales from its research models business also failed to impress.
The US FDA says its new screening system will expedite the importation of genuine drugs and help inspectors focus their efforts on “high risk” products.
Almost half of antimalarials in Senegal are substandard, according to a USP study which will be used by local regulators to focus efforts on high-risk products, brands and geographies.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including a new management team at a NextPharma site and appointments at Quintiles.
Integrated solutions are the future of trial data management according to Phase Forward as growth of the electronic data capture (EDC) market begins to slow.
Greater production efficiency, flexibility and state-of-the art capabilities are benefits that lids and shrink sleeve manufacturer Nyco said it can offer after investing in a new hybrid printing press.
BioClinica is providing Cephalon with end-to-end clinical data management services and hiring some of the biotech’s staff under a three-year, multi-million dollar deal.
The EFCG has welcomed the addition of excipient GMP requirements to the draft amendments of the EU falsified medicines directive but warned that deeper analysis is needed to establish which products warrant further regulation.
Improving healthcare infrastructure across the region and a large treatment-naïve patient population makes the Middle East and North Africa (MENA) an increasingly attractive destination for drug trials says ClinTec CEO Rabinder Buttar.
ISCO’s stem cell manufacturing facility has passed final building inspection, enabling it to implement the processes and cGMP standards needed to produce clinical-grade products.
In a busy week of Big Phama results Pfizer reports sales boost from Wyeth, Roche says Genentech hit profits and GSK unveils surge in Relenza sales and plans to expand R&D restructuring.
Oracle Health Sciences has launched pharmacovigilance software Argus Safety Suite 5.1 to help pharma and CROs meet regulatory compliance and support safety processes from clinical development through post-marketing.
TTP LabTech has launched a contract screening service to assist various aspects of clients’ drug development programmes, from target identification through to preclinical toxicology.
Schott AG has launched its InJentle syringe to improve the stability of highly sensitive drugs, which is a “major topic” for the company’s clients, according to a company director.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Genzyme strengthening its manufacturing team and Carl Icahn’s representative joining Adventrex’s board.
CRO Novella Clinical is providing OSI Pharmaceuticals with clinical research and related services over the next two years and will gain use of facilities in Boulder, Colorado, US as part of the deal.
Pall Life Sciences plans to shake up bioprocessing with a vibration-based filtering tech that can cut costs and simplify process design by combining harvest and clarification in the same system.
Belgium-based Galapagos NV has acquired Argenta Discovery for €16.5m ($23.1m), creating a drug discovery service company with 390 employees and estimated revenues of €70m.
ClearTrial says information is power in trial talks and claims its CTO software helped biotech firm save 20 per cent of bid cost through more informed negotiations with its CRO.
Biofem Pharmaceuticals and NAFDAC have launched an anti-counterfeiting pilot project in Nigeria, using a mobile authentication service (MAS) to validate if a medicine is genuine.
In-PharmaTechnologist presents a round up of recent developments in the field of drug delivery, with new deals for Starpharma and Penwest, and a regulatory filing for Hovione.
Global packaging giant Amcor today announced that its acquisition of Alcan Packaging had been completed as it spelled out what the move would mean for suppliers and customers.
